Aggressive non-Hodgkin’s lymphoma

References 

1. Cancer Research UK . UK Non-Hodgkin’s lymphoma statistics. Also available at: http://info.cancerresearchuk.org/cancerstats/types/nhl/?a=5441(accessed 1 Aug 2008)
2. The Non-Hodgkin’s Lymphoma Classification Project . A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909–3918
   • MEDLINE
3. Sehn LH, Berry B, Chhanabhai M, et al. Revised International prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109:1857–1861
   • MEDLINE
   • CrossRef
4. In:  Swerdlow SH,  Campo E,  Harris NL editor. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn.. IARC; 2008;
5. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Eng J Med. 1993;328:1002–1006
6. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Eng J Med. 2002;346:235–242
7. Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2005;23:4117–4126
   • MEDLINE
   • CrossRef
8. Pfreundschuh M, Trűmper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MinT) Group. Lancet Oncol. 2006;7:379–391
   • Abstract
   • Full Text
   • Full-Text PDF (160 KB)
   • CrossRef
9. Pfreundschuh M, Trűmper L, Kloess M, et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood. 2004;104:634–641
   • MEDLINE
   • CrossRef
10. Burkitt D. A sarcoma involving the jaws in African children. Br J Surgery. 1958;46:218–223
11. Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-cell lymphoma project. Blood. 2008;111:5496–5504
    • CrossRef